BreathEasy
RTI International and Virginia Commonwealth University
Asthma is a common chronic illness that affects more than 23 million adults in the U.S. In addition to respiratory symptoms associated with the disease, individuals with asthma are also more likely to experience depression and anxiety. RTI International and Virginia Commonwealth University will design a personal health application that builds on the latest clinical guidelines for treatment and self-monitoring for patients with asthma. Patients will interact with the application through smartphones, mobile devices and biomonitors to capture and report observations of daily living (ODLs) – such as use of controller and rescue medications, symptom levels, quality of life and smoking. Clinicians will utilize a Web-based dashboard that provides simple analysis and visualization tools that allow them to quickly view their patients’ data, evaluate their health statuses and communicate any changes in treatment or monitoring. By providing a clearer picture of their health in everyday life, the ODLs will be used by both the patients and their clinicians to make lifestyle and treatment adjustments to better manage asthma symptoms.
Interested in learning more?
- Read blog posts about this project
- Read the team's proposal
- Meet the BreathEasy team
- Review privacy and security law analysis
What the BreathEasy team is saying...
"With the technologies we're developing, patients and clinicians will be able to communicate more quickly and easily and more accurately track environmental and behavioral effects on our health."
Barbara Massoudi, M.P.H., Ph.D., Co-Principal Investigator
RTI International
“As physicians, we see patients with asthma and we ask how they are doing, but we have little information about how they are really doing between office visits. This technology is one that empowers patients and helps them get more involved with their health care by reporting between visits on their asthma symptoms, triggers and use of maintenance and rescue medications. This portable technology may help us stay more connected with our asthma patients and improve their care.”
Stephen Rothemich, M.D., Co-Principal Investigator
Virginia Commonwealth University, Department of Family Medicine
